loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 75373 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Fougera Pharmaceuticals Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BETAMETHASONE DIPROPIONATE (1)

    filter

    01 FOUGERA PHARMS (1)

    filter

    01 OINTMENT, AUGMENTED;TOPICAL (1)

    filter

    01 EQ 0.05% BASE (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Betamethasone Dipropionate

    PDF Supplier PDF
    URL Supplier Web Content
    OINTMENT, AUGMENTED;TO...
    EQ 0.05% BASE
    BETAMETHASONE DIPROPIO...
    USA
    75373
    1999-06-22
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 75373

    Looking for CTD TGA MCC DOSSIER APPLICATION 75373 1

    19

    Fougera Pharmaceuticals Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is BETAMETHASONE DIPROPIONATE, with a corresponding application number 75373 and regulatory information .

    proudly manufactured in the

    approval since 1999-06-22

    Fougera Pharmaceuticals Inc.'s BETAMETHASONE DIPROPIONATE OINTMENT, AUGMENTED;TOPICAL, medication with EQ 0.05% BASE of BETAMETHASONE DIPROPIONATE.

    Post Enquiry
    POST ENQUIRY